The importance of the patient voice to clinical evidence for rare disease and orphan medicines

0 Views
Published
How can patients’ and carers’ experiences help us to better understand rare conditions and ensure innovative treatments are made available? Regina Leadley (Consultant, Systematic Review, Mtech Access) outlines the importance of the patient voice in clinical evidence generation for orphan medicines and other rare disease treatments.

Watch the full webinar where we explore the strategic and tactical challenges facing orphan medicines looking to achieve market access, at: https://mtechaccess.co.uk/rare-disease-market-access-live-webinar/
Category
Health
Be the first to comment